قالب وردپرس درنا توس
Home / US / $ 572-million decision against Johnson & Johnson at the Landmark Opioid Trial

$ 572-million decision against Johnson & Johnson at the Landmark Opioid Trial



A judge in Oklahoma ruled Monday Johnson & Johnson, the bagged corporate giants, demanding that in the first lawsuit against an opioid manufacturer it cost $ 572 million for the destruction it inflicted to pay for prescription painkillers.

Johnson & Johnson, which had contracted with poppy seed companies in Tasmania, supplied 60 percent of opiate ingredients used by drug manufacturers for opioids such as oxycodone which the state had aggressively argued marketed opioids for Doctors and patients as safe and effective. Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson, produced her own opioids ̵

1; a pill which she sold in 2015, and a fentanyl patch she still makes.

"The opioid crisis is an imminent threat and threat to Oklahomans," said Judge Thad Balkman of Cleveland District Court when he announced his decision.

The groundbreaking verdict was a resounding victory for Oklahoma Attorney General Mike Hunter. The closely watched case could be a severe harbinger for around two dozen opioid manufacturers, distributors and retailers, who face more than 2,000 similar lawsuits nationwide. Johnson & Johnson, one of the largest healthcare companies in the world, said it would appeal.

Oklahoma, a largely rural state, suffers greatly from opioids. According to Hunter, 18 million opioid prescriptions were prescribed between 2015 and 2018 in a state of 3.9 million people. According to his office, approximately 6,000 Oklahomans have died from opioid overdoses since 2000, and thousands more suffer from addiction problems.


Source link